From: Evaluation of therapy management and outcome in Takotsubo syndrome
CMR parameters | |||
---|---|---|---|
CMR I n = 72 | CMR II n = 63 (88%) | p-value* | |
LV-EF (%) | 49.1 ± 10.1 | 64.1 ± 5.7 | < 0.001 |
LV-EDVI (ml/m2) | 76.2 ± 13.7 | 72.1 ± 13.9 | 0.198 |
T2 Volume (%) | 13.5 ± 11.3 | 0.6 ± 2.4 | < 0.001 |
LGE Volume (%) | 0.0 ± 0.0 | 0.0 ± 0.0 | |
Δ angiogram-CMR (d) | 2 (1–3.5) | ||
Δ CMR I-CMR II (months) | 2.3 (1.3–2.9) |